MarinosDalakasMD

PubMed

• 4 citations
  Advances in the therapeutic algorithm for myasthenia gravis.
  Marinos C Dalakas> ;Nature Reviews. Neurology. 2023 Jul 1
• 4 citations
  Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria.
  Nicholas H Chia, Andrew McKeon, Marinos C Dalakas, Eoin P Flanagan, James H Bower, Bryan T Klassen, Divyanshu Dubey, Nicholas L Zalewski, Dustin Duffy, Sean J Pittock,...> ;Annals of Clinical and Translational Neurology. 2023 Jul 1
• 3 citations
  Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.
  Marinos C Dalakas> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2023 May 1
• 4 citations
  Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.
  Marinos C Dalakas, Norman Latov, Krista Kuitwaard> ;Expert Review of Neurotherapeutics. 2023 Jan 23
• Late-onset stiff-person syndrome: challenges in diagnosis and management.
  Dalakas, M., Yi, J.> ;Therapeutic Advances in Neurological Disorders. 2023 Jan 1
• 2 citations
  Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis a...
  Marinos C Dalakas> ;Therapeutic Advances in Neurological Disorders. 2023 Jan 1
• Autoimmune inflammatory myopathies.
  Marinos C Dalakas> ;Handbook of Clinical Neurology. 2023 Jan 1
• 4 citations
  Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?
  Felix Kohle, Marinos C Dalakas, Helmar C Lehmann> ;Therapeutic Advances in Neurological Disorders. 2023 Jan 1
• Reader Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small-Fiber Neuropathy.
  Anne Louise Oaklander, Marinos C Dalakas> ;Neurology. 2022 Oct 11
• 6 citations
  The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders.
  Panos Stathopoulos, Marinos C Dalakas> ;Expert Review of Clinical Immunology. 2022 Sep 1
• 9 citations
  Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome.
  Jessica Yi, Marinos C Dalakas> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2022 Sep 1
• Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology.
  Marinos C Dalakas, Josep Dalmau> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2022 Jul 1
• 21 citations
  Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis.
  Marinos C Dalakas> ;Expert Review of Clinical Immunology. 2022 Jul 1
• 15 citations
  The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies.
  Luis A Querol, Hans-Peter Hartung, Richard A Lewis, Pieter A van Doorn, Timothy R Hammond, Nazem Atassi, Miguel Alonso-Alonso, Marinos C Dalakas> ;Neurotherapeutics. 2022 Apr 1
• 19 citations
  Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases.
  Panos Stathopoulos, Marinos C Dalakas> ;Neurotherapeutics. 2022 Apr 1
• 1 citations
  Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis.
  Marinos C Dalakas, Andreas Meisel> ;Expert Review of Neurotherapeutics. 2022 Apr 1
• Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies.
  Marinos C Dalakas, Heinz Wiendl> ;Neurotherapeutics. 2022 Apr 1
• 28 citations
  Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.
  Marinos C Dalakas> ;Neurotherapeutics. 2022 Apr 1
• 12 citations
  Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits.
  Marinos C Dalakas> ;Expert Review of Clinical Immunology. 2022 Apr 1
• Progressive multifocal fibrosing neuropathy: description of a novel disease.
  Fabian A Mendoza, Jennifer Bagley, Michael Gochfeld, Marinos C Dalakas, John L Farber, Sergio A Jimenez> ;Acta Neuropathologica Communications. 2022 Mar 16
• 17 citations
  Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies.
  Marinos C Dalakas> ;Neurotherapeutics. 2022 Apr 1
• 18 citations
  IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti-B Cell Therapies.
  Marinos C. Dalakas> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2022 Jan 1
• 2 citations
  Unconvincing Evidence of SARS-CoV-2-Associated Myositis in Autopsied Muscles.
  Marinos C. Dalakas> ;JAMA Neurology. 2021 Nov 22
• 35 citations
  Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
  Marinos C. Dalakas> ;Neurotherapeutics. 2021 Nov 11
• 4 citations
  Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data.
  Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Maria-Eleftheria Evangelopoulos, George Velonakis, George P. Chrousos, Marinos C. Dalakas, Leonidas Stefanis, M...> ;Neurological Sciences. 2021 Oct 1
• Join now to see all